Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer

Cancer Chemotherapy and Pharmacology

Volumn 77, Issue 5, 2016, Pages 1061-1067

  Shang, Chao ^a   Guo, Yan ^a   Zhang, Jiaxing ^a   Huang, Baojun ^a,b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Adriamycin; Chemotherapy; Gastric cancer; Long noncoding RNA; UCA1

Indexed keywords

DOXORUBICIN; LONG UNTRANSLATED RNA; PARP PROTEIN; PROTEIN; PROTEIN BCL 2; UNCLASSIFIED DRUG; UROTHELIAL CARCINOMA ASSOCIATED 1 PROTEIN; ANTINEOPLASTIC ANTIBIOTIC; TUMOR MARKER; UCA1 RNA, HUMAN;

APOPTOSIS; ARTICLE; CANCER STAGING; CELL PROLIFERATION; CHEMOSENSITIVITY; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FLOW CYTOMETRY; GASTRIC CANCER CELL LINE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MTT ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; SURVIVAL TIME; TUMOR INVASION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ADULT; AGED; DOWN REGULATION; DRUG EFFECTS; DRUG RESISTANCE; EPITHELIUM CELL; FEMALE; GENE SILENCING; GENETICS; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; FEMALE; GENE SILENCING; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RNA, LONG NONCODING; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84964053087     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-016-3029-3     Document Type: Article

References (28)

1. Sugano K (2015) Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol 29 (6): 895-905
2. Newton AD, Datta J, Loaiza-Bonilla A, Karakousis GC, Roses RE (2015) Neoadjuvant therapy for gastric cancer: current evidence and future directions. J Gastrointest Oncol 6 (5): 534-543
3. Xu XD, Li KR, Li XM, Yao J, Qin J, Yan B (2014) Long noncoding RNAs: new players in ocular neovascularization. Mol Biol Rep 41 (7): 4493-4505
4. Zhao Y, Feng G, Wang Y, Yue Y, Zhao W (2014) Regulation of apoptosis by long non-coding RNA HIF1A-AS1 in VSMCs: implications for TAA pathogenesis. Int J Clin Exp Pathol 7 (11): 7643-7652
5. Song J, Ahn C, Chun CH, Jin EJ (2014) A long non-coding RNA, GAS5, plays a critical role in the regulation of miR-21 during osteoarthritis. J Orthop Res 32 (12): 1628-1635
6. Modali SD, Parekh VI, Kebebew E, Agarwal SK (2015) Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors. Mol Endocrinol 29 (2): 224-237
7. Wang X, Li M, Wang Z, Han S, Tang X, Ge Y, Zhou L, Zhou C, Yuan Q, Yang M (2015) Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration and invasion of esophageal squamous cell carcinoma cells. J Biol Chem 290 (7): 3925-3935
8. Li HJ, Li X, Pang H, Pan JJ, Xie XJ, Chen W (2015) Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer. Jpn J Clin Oncol 45 (11): 1055-1063
9. Na XY, Liu ZY, Ren PP, Yu R, Shang XS (2015) Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. Int J Clin Exp Med 8 (8): 12609-12616
10. Tuo YL, Li XM, Luo J (2015) Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol Sci 19 (18): 3403-3411
11. Zheng Q, Wu F, Dai WY, Zheng DC, Zheng C, Ye H, Zhou B, Chen JJ, Chen P (2015) Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol 17 (8): 640-646
12. Shang C, Guo Y, Hong Y, Liu YH, Xue YX (2015) MiR-21 upregulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG. Mol Biol Rep 42 (3): 721-727
13. Zhang Y, Qu X, Li C, Fan Y, Che X, Wang X, Cai Y, Hu X, Liu Y (2015) miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1. Tumour Biol 36 (4): 2277-2285
14. Alaimo S, Giugno R, Pulvirenti A (2014) ncPred: ncRNA-disease association prediction through tripartite network-based inference. Front Bioeng Biotechnol 2: 71
15. Fang TT, Sun XJ, Chen J, Zhao Y, Sun RX, Ren N, Liu BB (2014) Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential. Asian Pac J Cancer Prev 15 (23): 10513-10524
16. Nie F, Sun M, Yang J, Xie M, Xu TP, Xia R, Liu YW, Liu XH, Zhang EB, Lu KH, Shu YQ (2015) Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther 14 (1): 268-277
17. Wang Y, Liu X, Zhang H, Sun L, Zhou Y, Jin H, Zhang H, Zhang H, Liu J, Guo H, Nie Y, Wu K, Fan D, Zhang H, Liu L (2014) Hypoxia-inducible lncRNA-AK058003 promotes gastric cancer metastasis by targeting γ-synuclein. Neoplasia 16 (12): 1094-1106
18. Wang Y, Guo Q, Zhao Y, Chen J, Wang S, Hu J, Sun Y (2014) BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma. Oncol Lett 8 (5): 1947-1952
19. Banet G, Bibi O, Matouk I, Ayesh S, Laster M, Kimber KM, Tykocinski M, de Groot N, Hochberg A, Ohana P (2000) Characterization of human and mouse H19 regulatory sequences. Mol Biol Rep 27 (3): 157-165
20. Kraus TF, Greiner A, Guibourt V, Lisec K, Kretzschmar HA (2015) Identification of stably expressed lncRNAs as valid endogenous controls for profiling of human glioma. J Cancer 6 (2): 111-119
21. Zhao W, Dong S, Duan B, Chen P, Shi L, Gao H, Qi H (2015) HOTAIR is a predictive and prognostic biomarker for patients with advanced gastric adenocarcinoma receiving fluorouracil and platinum combination chemotherapy. Am J Transl Res 7 (7): 1295-1302
22. Sun J, Song Y, Chen X, Zhao J, Gao P, Huang X, Xu H, Wang Z (2015) Novel long non-coding RNA RP11-119F7. 4 as a potential biomarker for the development and progression of gastric cancer. Oncol Lett 10 (1): 115-120
23. Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, Zhang Y, Xin DQ, Na YQ, Chen WF (2006) Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 12 (16): 4851-4858
24. Chen S, Shao C, Xu M, Ji J, Xie Y, Lei Y, Wang X (2015) Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA UCA1. Int J Clin Exp Pathol 8 (8): 9052-9061
25. Wang F, Zhou J, Xie X, Hu J, Chen L, Hu Q, Guo H, Yu C (2015) Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1in human ovarian cancer cells. Neoplasma 62 (3): 432-438
26. Yang C, Li X, Wang Y, Zhao L, Chen W (2012) Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene 496 (1): 8-16
27. Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y (2014) Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J 281 (7): 1750-1758
28. Hong Y, Shang C, Xue YX, Liu YH (2015) Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human glioblastoma cells. Med Sci Monit 21: 1002-1007